Literature DB >> 18450497

Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan.

Chin-Song Lu1, Hsiu-Chen Chang, Yi-Hsin Weng, Rou-Shayn Chen, Vincenzo Bonifati, Yah-Huei Wu-Chou.   

Abstract

The c.G7153A variant in the LRRK2 gene (protein effect: Gly2385Arg) is emerging as an important risk factor for Parkinson's disease (PD) in the Han Chinese and Japanese populations. The prevalence of this variant in other neurodegenerative diseases and movement disorders remains almost completely unexplored. Using MALDI-TOF, we studied the Gly2385Arg variant in a large cohort of patients with primary dystonia (n=335) and a smaller series of patients with clinically diagnosed multiple system atrophy (MSA, n=57). The Gly2385Arg variant was identified in heterozygous state in 14 patients with primary dystonia (4.18%) and in three patients with MSA (5.26%). These frequencies do not differ statistically from that reported previously by us in Taiwanese controls (5%). We conclude that the Gly2385Arg variant is not associated with primary dystonia in Taiwan, supporting the specificity of the association between this variant and PD. Whether the Gly2385Arg variant modifies the risk for MSA deserves further study in larger samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450497     DOI: 10.1016/j.parkreldis.2008.03.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  2 in total

1.  Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation.

Authors:  Giulietta Maria Riboldi; Jose-Alberto Palma; Etty Cortes; Megan A Iida; Tamjeed Sikder; Brooklyn Henderson; Towfique Raj; Ruth H Walker; John F Crary; Horacio Kaufmann; Steven Frucht
Journal:  Mov Disord       Date:  2019-05-11       Impact factor: 10.338

2.  LRRK2 exonic variants and risk of multiple system atrophy.

Authors:  Michael G Heckman; Lucia Schottlaender; Alexandra I Soto-Ortolaza; Nancy N Diehl; Sruti Rayaprolu; Kotaro Ogaki; Shinsuke Fujioka; Melissa E Murray; William P Cheshire; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer; Anna Sailer; Andrew B Singleton; Patrick F Chinnery; Michael J Keogh; Steve M Gentleman; Janice L Holton; Kiely Aoife; David M A Mann; Safa Al-Sarraj; Claire Troakes; Dennis W Dickson; Henry Houlden; Owen A Ross
Journal:  Neurology       Date:  2014-11-05       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.